Integra LifeSciences | IART - 营业费用

股票价格
10.57
每天变化
0.25 2.42%
每月一次
10.68%
每年
-37.12%
Q2 预测
10.34


金融业
股票价格
USD
资产
USD 3.6B
现金及等价物
USD 235.05M
销售成本
USD 193.45M
流动资产
USD 1.16B
流动负债
USD 455.98M
债务
USD 2.01B
EBIT
USD 66.01M
EBITDA
USD 104.21M
员工
4.4K
EPS每股收益
USD 0.83
股本和储备
USD 1.04B
销售毛利
USD 217.1M
债务利息支出
USD 23.67M
利息收入
USD 4.98M
贷款资金
USD 1.86B
市值
USD 807.2M
净收入
USD -1.7M
营业费用
USD 368.92M
营业利润
USD 66.01M
普通股股本
USD 77.89M
PE价格收益
6.59
税前利润
USD -6.82M
销售收入
USD 434.9M
销售和管理费用
USD 156.45M
股票
USD 492.74M
贸易债权人
USD 95.73M
应收帐款人
USD 278.85M


营业费用 更改 日
Abbott USD 9.31B 104M 2026-03
AtriCure USD 138.01M 3.95M 2025-12
Baxter International USD 3.19B 554.4M 2025-12
Becton, Dickinson and Co. USD 4.59B 476M 2025-12
Boston Scientific USD 4.04B 18M 2025-12
CONMED USD 336.58M 10.53M 2025-12
Cooper Companies USD 811.3M 113.5M 2025-12
Dexcom USD 936.6M 30.2M 2025-12
Edwards Lifesciences USD 1.13B 65.4M 2026-03
Globus Medical USD 645.11M 241.46M 2025-12
HeartBeam USD 5.31M 20K 2025-12
Insulet USD 637.5M 48.9M 2025-12
Integra LifeSciences USD 368.92M 668.65M 2025-12
Intuitive Surgical USD 1.91B 89.8M 2026-03
J&J USD 17.44B 1.53B 2026-03
Medtronic USD 7.28B 16M 2025-12
Merit Medical Systems USD 339.74M 1.8M 2025-12
Orthofix International USD 213.79M 12.36M 2025-12
Smith & Nephew USD 2.52B 84M 2025-12
Stryker USD 5.2B 505M 2025-12
Tandem Diabetes Care USD 282.09M 9.97M 2025-12
Teleflex USD 532.64M 3.29B 2025-12
Zimmer Biomet Holdings USD 1.94B 277.8M 2025-12